about
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogsMorpholino antisense oligonucleotides: tools for investigating vertebrate development.Crystal Structure of Chiral γPNA with Complementary DNA Strand: Insights into the Stability and Specificity of Recognition and Conformational PreorganizationMapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase.Synthesis and hybridization properties of oligonucleotides containing (2S,3R)-9-(2,3,4-trihydroxybutyl)adenine.Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAsIn vivo imaging with oligonucleotides for diagnosis and drug development.Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.Potent and nontoxic antisense oligonucleotides containing locked nucleic acidsSynthesis of conformationally preorganized and cell-permeable guanidine-based gamma-peptide nucleic acids (gammaGPNAs).Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5Radiolabeled oligonucleotides for antisense imaging.Elk-1, C/EBPalpha, and Pit-1 confer an insulin-responsive phenotype on prolactin promoter expression in Chinese hamster ovary cells and define the factors required for insulin-increased transcription.Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond.Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.Artificial neural network prediction of antisense oligodeoxynucleotide activityNon-coding RNAs as drug targets.siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.Polymorphisms in the large subunit of human RNA polymerase II as target for allele-specific inhibitionSynthesis, thermal stability and resistance to enzymatic hydrolysis of the oligonucleotides containing 5-(N-aminohexyl)carbamoyl-2'-O-methyluridines.Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes.Prediction of antisense oligonucleotide efficacy using aggregate motifs.Ezrin mRNA target site selection for DNAzymes using secondary structure and hybridization thermodynamics.Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids.Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.
P2860
Q24555118-641F2F14-13A8-4AA6-9D66-7713C96F6446Q24805526-7972BDA1-DE4F-4921-B196-6EF2F56755DCQ27663846-1BBCA29C-F04B-4972-8E6B-9F16E11491C2Q30662658-E0CC3A3F-5E78-43B2-91EF-97171AB0909DQ33250055-92B28986-19BA-4389-A7A6-7F75F9FC2283Q35110193-0DF0F7DA-14D6-4838-AAD2-8F417AB61225Q35127223-68ACF2CA-B9CB-4598-8928-CE8BA5FB9E7EQ36742412-24B819FD-F518-407F-B430-6366EC39B69FQ36985622-37CA7247-58C6-4607-B31E-D44654ABA5BBQ37115025-AC791C8F-E878-4073-8621-EED7DFB63496Q37167989-F9A76F55-9D5A-4469-960C-496ADABC83CCQ37913042-5C141852-35F3-45E3-A379-F68B99CBB902Q38301135-EDBF550C-677A-4940-A405-1D7225DB8A25Q38303734-9C2C42C9-9753-4735-A63A-6B16A511ACFAQ38320343-82BE6DA2-ED45-4091-AEE8-3B3395D3AD9FQ38362285-4A836E62-DBE9-44DD-83EA-469FEBA8B493Q38904908-489D4F62-C7E0-439A-9042-B21BB86F6A79Q39404757-C9867C13-EB2D-46D4-AC71-5FF23C82A449Q39542570-AA76A461-0317-400B-B855-C16A9FE25BC4Q39756314-6B582CE3-060B-4BB7-AE7B-81BA027A87CAQ40799550-AB757E72-1609-4675-B2BA-E51E5C312A97Q44224622-B90C5FE1-6B49-48D7-9078-CF97E3D217F0Q45869957-20E77135-2E9A-48BF-BA80-540E9EB898D4Q46891008-19A95208-B541-4FAB-B54D-6255418FB818Q48569299-62845177-DC4C-4A02-898F-C6A1933D9554
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Keeping the biotechnology of antisense in context.
@en
Keeping the biotechnology of antisense in context.
@nl
type
label
Keeping the biotechnology of antisense in context.
@en
Keeping the biotechnology of antisense in context.
@nl
prefLabel
Keeping the biotechnology of antisense in context.
@en
Keeping the biotechnology of antisense in context.
@nl
P2860
P356
P1433
P1476
Keeping the biotechnology of antisense in context.
@en
P2093
P2860
P2888
P356
10.1038/6909
P577
1999-03-01T00:00:00Z